Adalimumab plus methotrexate or standard therapy is more effective than methotrexate or standard therapies alone in the treatment of fatigue in patients with active, inadequately treated rheumatoid arthritis.
Year: 2007
Type: article
Source: PubMed
Authors: S Yount, M V Sorensen, D Cella, N Sengupta, J Grober, E K Chartash
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2402870358